Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers

C. Theodore; L. Geoffrois; J.B. Vermorken; F. Caponigro; W. Fiedler; P. Chollet; A. Ravaud; G.J. Peters; C. de Balincourt; D Lacombe; P Fumoleau

doi:10.1016/j.ejca.2005.02.015

Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers

C. Theodore, L. Geoffrois, J.B. Vermorken, F. Caponigro, W. Fiedler, P. Chollet, A. Ravaud, G.J. Peters, C. de Balincourt, D Lacombe, P Fumoleau

VU University medical center

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1150-1157
Journal	European Journal of Cancer
Volume	41
Issue number	8
DOIs	https://doi.org/10.1016/j.ejca.2005.02.015
Publication status	Published - 2005

Access to Document

10.1016/j.ejca.2005.02.015

Embargoed Document

188993
Final published version, 130 KB

Cite this

Theodore, C., Geoffrois, L., Vermorken, J. B., Caponigro, F., Fiedler, W., Chollet, P., Ravaud, A., Peters, G. J., de Balincourt, C., Lacombe, D., & Fumoleau, P. (2005). Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers. European Journal of Cancer, 41(8), 1150-1157. https://doi.org/10.1016/j.ejca.2005.02.015

@article{2fab0e1ad57c490797769e7c322ed319,

title = "Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers",

author = "C. Theodore and L. Geoffrois and J.B. Vermorken and F. Caponigro and W. Fiedler and P. Chollet and A. Ravaud and G.J. Peters and {de Balincourt}, C. and D Lacombe and P Fumoleau",

year = "2005",

doi = "10.1016/j.ejca.2005.02.015",

language = "English",

volume = "41",

pages = "1150--1157",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Pergamon",

number = "8",

}

Theodore, C, Geoffrois, L, Vermorken, JB, Caponigro, F, Fiedler, W, Chollet, P, Ravaud, A, Peters, GJ, de Balincourt, C, Lacombe, D & Fumoleau, P 2005, 'Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers', European Journal of Cancer, vol. 41, no. 8, pp. 1150-1157. https://doi.org/10.1016/j.ejca.2005.02.015

Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers. / Theodore, C.; Geoffrois, L.; Vermorken, J.B. et al.

In: European Journal of Cancer, Vol. 41, No. 8, 2005, p. 1150-1157.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers

AU - Theodore, C.

AU - Geoffrois, L.

AU - Vermorken, J.B.

AU - Caponigro, F.

AU - Fiedler, W.

AU - Chollet, P.

AU - Ravaud, A.

AU - Peters, G.J.

AU - de Balincourt, C.

AU - Lacombe, D

AU - Fumoleau, P

PY - 2005

Y1 - 2005

U2 - 10.1016/j.ejca.2005.02.015

DO - 10.1016/j.ejca.2005.02.015

M3 - Article

SN - 0959-8049

VL - 41

SP - 1150

EP - 1157

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 8

ER -